看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | 3.8x - 4.2x | 4.0x |
| Historical Pb Multiple | 2.7x - 6.7x | 3.6x |
| Fair Value | ﷼134.15 - ﷼148.27 | ﷼141.21 |
| Upside | 9.1% - 20.5% | 14.8% |
| Benchmarks | - | Full Ticker |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| National Medical Care Company | 400,500.0% | SASE:4005 |
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| Dallah Healthcare Company | 400,400.0% | SASE:4004 |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4007 | 4005 | 4002 | 4013 | 4009 | 4004 | |||
| SASE:4007 | SASE:4005 | SASE:4002 | SASE:4013 | SASE:4009 | SASE:4004 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 29.5% | 30.1% | 8.9% | 21.6% | 23.6% | 20.5% | ||
| 3Y CAGR | 50.8% | 29.8% | 3.8% | 18.9% | 154.0% | 39.7% | ||
| Latest Twelve Months | 11.7% | 23.8% | -1.8% | 13.2% | 56.5% | 30.8% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 19.5% | 17.5% | 26.5% | 19.8% | 4.7% | 12.6% | ||
| Prior Fiscal Year | 25.8% | 22.3% | 24.3% | 21.5% | 6.8% | 11.0% | ||
| Latest Fiscal Year | 29.4% | 23.0% | 22.4% | 20.7% | 9.8% | 12.2% | ||
| Latest Twelve Months | 29.4% | 23.0% | 22.4% | 20.7% | 9.8% | 14.7% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 11.1% | 13.8% | 22.8% | 28.1% | 7.5% | 12.3% | ||
| Prior Fiscal Year | 17.1% | 17.7% | 21.2% | 33.1% | 12.5% | 13.9% | ||
| Latest Twelve Months | 17.8% | 19.3% | 18.9% | 33.9% | 17.5% | 14.1% | ||
| Next Fiscal Year | 16.6% | 18.1% | 22.7% | 33.4% | 15.2% | 13.6% | ||
| Two Fiscal Years Forward | 16.1% | 19.3% | 20.8% | 36.1% | 16.1% | 14.5% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 5.7x | 5.6x | 5.1x | 8.4x | 2.2x | 3.8x | ||
| Price / LTM EPS | 19.4x | 24.4x | 22.6x | 40.7x | 22.7x | 25.6x | ||
| Price / Book | 3.3x | 4.5x | 4.1x | 13.1x | 3.8x | 3.5x | ||
| Price / Fwd Book | 3.2x | 4.0x | 3.6x | 11.6x | 3.3x | 3.2x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 3.3x | 4.1x | 13.1x | |||||
| Historical P/B Ratio | 2.7x | 3.6x | 6.7x | |||||
| Selected P/B Multiple | 3.8x | 4.0x | 4.2x | |||||
| (x) Book Value | 3,469 | 3,469 | 3,469 | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4007 | 4005 | 4002 | 4013 | 4009 | 4004 | |
| Value of Common Equity | 6,608 | 7,221 | 14,720 | 94,080 | 6,443 | 11,968 | |
| (/) Shares Outstanding | 160.0 | 44.9 | 200.0 | 350.0 | 92.0 | 97.3 | |
| Implied Stock Price | 41.30 | 161.00 | 73.60 | 268.80 | 70.00 | 123.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 41.30 | 161.00 | 73.60 | 268.80 | 70.00 | 123.00 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |